BAXTER HEALTHCARE CORP
BAXTER HEALTHCARE CORP (United States) holds 3 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 3 active ingredients and is linked to 8 FDA-registered manufacturing sites. 50 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “BAXTER HEALTHCARE CORP: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/baxter-healthcare-corp
Overview
BAXTER HEALTHCARE CORP is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CYCLOPHOSPHAMIDE, USP/EP; IFOSFAMIDE USP/EP; MESNA, USP/EP DRUG SUBSTANCE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which BAXTER HEALTHCARE CORP holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
BAXTER HEALTHCARE CORP holds 3 active (6 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- MESNA, USP/EP DRUG SUBSTANCEActive2011-09-08
- CYCLOPHOSPHAMIDE, USP/EPActive1979-06-11
- IFOSFAMIDE USP/EPActive1979-04-24
- MURINE MONOCLONAL ANTIBODIES (ANTI-CD8/CD4) TO HUMAN T-CELLSInactive2005-08-23
- ANTI-PROTEIN C AFFINITY MATRIXInactive1990-12-21
- FACILITIES IN MORTON GROVE, IL AND BRIDGEPORT, NJInactive1988-07-12
Registered manufacturing sites (8)
Physical sites registered with the US FDA and resolved to BAXTER HEALTHCARE CORP, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- Baxter Deutschland GmbHBielefeld, Germany · API manufactureSite GMP match
- Baxter Healthcare CorporationGuayama, United States · API manufacture
- Baxter Healthcare CorporationMarion, United States · API manufacture
- Baxter Healthcare LtdThetford, United Kingdom · Analytical testing · Labelling
- BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITEDAhmedabad, India · Analytical testing · LabellingSite GMP match
- Baxter R and D EuropeBraine l� Alleud, Belgium · Analytical testing
- Baxter SALessines, Belgium · Analytical testing · LabellingSite GMP match
- Bieffe Medital SASabinanigo (Senegue), Spain · Analytical testing · LabellingSite GMP match
FDA compliance signals
50 FDA enforcement records linked to this company.
- warning_letter2026-09-29
FDA Warning Letter (drug product)
- 4832026-09-23
Procedures for sterile drug products
- 4832026-09-23
Investigations of discrepancies, failures
- 4832026-09-23
Control procedures to monitor and validate performance
- 4832026-09-23
Procedures not in writing, fully followed
- 4832026-09-23
SOPs not followed / documented
- recall — Class I2026-09-16
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class I2026-09-09
Presence of particulate matter: Particulates identified as fiberglass
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class II2026-09-09
CGMP Deviations
- recall — Class I2026-08-19
Presence of Particulate Matter
- 4832026-04-02
Investigations of discrepancies, failures
- 4832026-04-02
Written procedures not established/followed
- 4832026-04-02
Training--operations, GMPs, written procedures
- 4832026-04-02
Procedure Deviations Recorded and Justified
- 4832026-04-02
Equipment Design, Size and Location
- 4832026-04-02
Defined areas of adequate size for operations
- 4832026-04-02
Validation lacking for sterile drug products
- 4832026-04-02
Following/documenting laboratory controls
- 4832026-04-02
Acceptance/Rejection Levels
- recall — Class II2026-02-04
Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution
- 4832025-11-25
Computer control of master formula records
- 4832025-11-25
Sample identification and other information
- 4832025-11-25
Procedures not in writing, fully followed
- 4832025-11-25
Scientifically sound laboratory controls
- 4832025-11-25
Training , Education , Experience overall
- 4832025-09-29
Scientifically sound laboratory controls
- 4832025-09-29
Backup data not assured as exact and complete
- 4832025-09-29
Cleaning / Sanitizing / Maintenance
- 4832025-09-29
Buildings not maintained in good state of repair
- 4832025-09-29
Investigations of discrepancies, failures
- recall — Class II2025-09-03
Discoloration
- 4832025-03-26
Procedures not in writing, fully followed
- recall — Class II2024-11-13
Labeling: Missing Label
- recall — Class I2024-09-11
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Is this BAXTER HEALTHCARE CORP?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.